Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
33.99
+0.12 (0.35%)
At close: Mar 9, 2026, 4:00 PM EDT
34.00
+0.01 (0.02%)
After-hours: Mar 9, 2026, 7:24 PM EDT
Corcept Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 99.65 | 141.21 | 106.14 | 101.42 | 112.51 | |
| Depreciation & Amortization | 1.89 | 1.34 | 2.36 | 3.45 | 3.48 | |
| Loss (Gain) From Sale of Investments | -5.1 | -10.94 | -9.13 | 1.38 | - | |
| Stock-Based Compensation | 84.5 | 61.35 | 48.94 | 42.44 | 42.93 | |
| Other Operating Activities | -37.54 | -40.19 | -29.49 | -33.91 | 9.44 | |
| Change in Accounts Receivable | -5.81 | -12.85 | -10.07 | -3.43 | -1.43 | |
| Change in Inventory | -7.48 | 0.31 | 1.27 | 1.2 | 3.44 | |
| Change in Accounts Payable | 25.07 | -2.02 | 5.42 | 4.76 | -3.6 | |
| Change in Income Taxes | 1.09 | 3.78 | 1.21 | 8.69 | 0.01 | |
| Change in Other Net Operating Assets | -14.28 | 56.32 | 10.03 | -5.67 | 1.1 | |
| Operating Cash Flow | 142 | 198.3 | 126.68 | 120.32 | 167.89 | |
| Operating Cash Flow Growth | -28.39% | 56.53% | 5.28% | -28.33% | 10.48% | |
| Capital Expenditures | -0.21 | -2.17 | -0.14 | -0.41 | -0.47 | |
| Investment in Securities | 69.97 | -175.43 | 91.05 | -113.91 | 136.6 | |
| Investing Cash Flow | 69.76 | -177.6 | 90.91 | -114.33 | 136.13 | |
| Issuance of Common Stock | 25.49 | 9.62 | 5.81 | 4.38 | 16.23 | |
| Repurchase of Common Stock | -245.86 | -37.97 | -154.53 | -21.67 | -318.82 | |
| Financing Cash Flow | -220.37 | -28.35 | -148.72 | -17.28 | -302.59 | |
| Foreign Exchange Rate Adjustments | 1.44 | -0.23 | 0.36 | - | - | |
| Net Cash Flow | -7.17 | -7.89 | 69.22 | -11.29 | 1.43 | |
| Free Cash Flow | 141.79 | 196.12 | 126.54 | 119.91 | 167.42 | |
| Free Cash Flow Growth | -27.71% | 54.99% | 5.53% | -28.38% | 11.07% | |
| Free Cash Flow Margin | 18.62% | 29.05% | 26.23% | 29.84% | 45.75% | |
| Free Cash Flow Per Share | 1.18 | 1.73 | 1.13 | 1.03 | 1.33 | |
| Cash Income Tax Paid | 12.97 | 60.27 | 47.6 | 39.75 | 9.1 | |
| Levered Free Cash Flow | 114.19 | 183.85 | 128.39 | 115.55 | 120.18 | |
| Unlevered Free Cash Flow | 114.19 | 183.85 | 128.39 | 115.55 | 120.18 | |
| Change in Working Capital | -1.41 | 45.53 | 7.86 | 5.54 | -0.47 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.